Literature DB >> 6785627

[Clinical experience with fosfomycin in urinary tract infections (author's transl)].

H J Peters, R Eicher.   

Abstract

Fosfomycin, an antibiotic from a new class of substances, has a bactericidal action against a broad spectrum of gram-positive and gram-negative organisms. The efficacy of fosfomycin in urinary tract infections was investigated with a dose of 15 g/day. 52 urological patients with obstructive and non-obstructive infections of the urinary tract were accepted for the study. The therapeutic success was convincing: 91% of the pathogens were eliminated from the urine, the urine was free from organisms in 84% of the patients after the treatment. 93% were clinically symptomless. The effects against Pseudomonas was very good: 8 of 9 strains present were eliminated. Unpleasant gastrointestinal side effects occurred which were dependent on the rate of infusion and usually became tolerable at a slower rate.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6785627

Source DB:  PubMed          Journal:  MMW Munch Med Wochenschr        ISSN: 0341-3098


  1 in total

1.  In vitro activity of fosfomycin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus.

Authors:  W Graninger; T Leitha; M Havel; A Georgopoulos
Journal:  Infection       Date:  1984 Jul-Aug       Impact factor: 3.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.